# Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue Defects

> **NCT05239130** · NA · UNKNOWN · sponsor: **I.R.A. Istituto Ricerche Applicate S.p.A.** · enrollment: 48 (actual)

## Conditions studied

- Cicatrix
- Lipodystrophy
- Plaque

## Interventions

- **DEVICE:** Auralya

## Key facts

- **NCT ID:** NCT05239130
- **Lead sponsor:** I.R.A. Istituto Ricerche Applicate S.p.A.
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-21
- **Primary completion:** 2022-12-11
- **Final completion:** 2022-12-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05239130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05239130, "Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue Defects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05239130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*